Case Study

International Lung Cancer Study: How We Reached 100% of Our Recruitment Scope Seven Months Ahead Of Schedule

Lung--Cancer-GettyImages-103990748

One of the world's leading biopharmaceutical companies with Korean origins ran a clinical trial for its own biosimilar product in 13 countries. palleos healthcare was contracted as a local CRO and was responsible for running full-scale clinical trial activities with the recruitment goal of 254 patients across 21 research sites. Whereas the Global CRO recruited 509 patients at 79 sites in countries, including Germany, Spain, Serbia, Georgia, South Korea, and Taiwan.

This was a Phase III, randomized, comparative, double-blind, two-parallel group, multicenter study in subjects with metastatic or recurrent non-squamous non-small cell lung cancer. The aim of the study was to demonstrate the efficacy, safety, pharmacokinetics, and immunogenicity of the investigational drug (biosimilar) compared to a comparator during a 24-week chemotherapy period.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Hydrocarbon Online